Biopharma
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global biopharma insights for investors & BD. Track drug development, M&A, and market trends shaping the pharmaceutical landscape.
Showing 49–60 of 69 articles
Impact of COINS Act Expansion on China Biotech Licensing
GOP Lawmaker Urges Action on China Biotech Deals
Merck-Kelun ADC's Strategic Wins and Takeda's Antitrust Loss
Incyte's Strategic AI Partnerships: Implications for Pharma
Parabilis IPO Plans Following Regeneron Deal: What You Need to Know
Bristol Myers Expands AI Capabilities with Anthropic Partnership
Supreme Court Decision on IRA Challenges: Implications for Pharma
Top 10 Biopharma M&A Deals of 2025: Market Analysis
Regeneron Secures $125M Parabilis Deal for Drug Targets
Pfizer's Latest Developments: Insights for Investors and Executives
U.K. Advocacy Groups Challenge U.S. Pharma Trade Deal
Biopharma M&A Trends: Resilience Amidst Large Deal Decline